Synthetic Peptides intermediate
Tisotumab Vedotin: Oligopeptide Research Reference
Tisotumab Vedotin, a bioactive peptide compound with documented applications in biomedical research, pharmacological studies, and therapeutic development
By Encyclopeptide Editorial | 1 min read
synthetic-peptides peptide oligopeptide
Overview
Tisotumab Vedotin is a bioactive peptide with well-characterized properties and therapeutic applications.
Structure
| Property | Value |
|---|---|
| Name | Tisotumab Vedotin |
| Sequence | Anti-TF antibody - Val-Cit linker - MMAE |
| Length | Antibody + linker-payload |
| Molecular Weight | ~150 kDa (antibody component) |
| Category | Peptide Drug Conjugates |
Mechanism of Action
Targets TF-expressing tumor cells, delivers MMAE intracellularly after linker cleavage by lysosomal proteases
References
- Wikipept Peptide Database
- Primary literature (see individual entries)
Test Your Knowledge
Reinforce what you learned about Tisotumab Vedotin: Oligopeptide Research Reference with interactive quizzes on Wikipept.
Take a Quiz on Wikipept